Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience

Introduction. Hepatitis C (HCV) continues to be the leading indication for liver transplantation (LT). Sustained virological response (SVR) rates to pegylated interferon (PEG-IFN) and ribavirin (RBV) therapy for recurrent HCV in Genotype 1 (G1) LT recipients have been disappointing (30-40%). Experie...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nabiha Faisal, MD, FCPS, Eric M. Yoshida, Marc Bilodeau, Philip Wong, Mang Ma, Kelly W. Burak, Bandar Al-Judaibi, Eberhard L. Renner, Leslie B. Lilly
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2014-09-01
coleção:	Annals of Hepatology
Assuntos:	Boceprevir Telaprevir Sustained virological response Early virological response Drug-drug interaction
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S1665268119312529
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!